Patents for A61P 27 - Drugs for disorders of the senses (53,017)
04/1995
04/25/1995US5409913 Oxazocinyl/thiazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/23/1995CA2133939A1 1,2-dihydro-2-oxo-pyridines
04/20/1995WO1995010280A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
04/20/1995WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/19/1995EP0648206A1 Peptidyl derivatives and their use as metalloproteinase inhibitors
04/19/1995EP0648131A1 Ophthalmic compositions and methods for preserving and using same
04/19/1995EP0648118A1 Methods and products for treating presbyopia
04/19/1995EP0243446B1 Alpha tocopherol-based vesicles
04/19/1995CN1101780A Method and means for preventing secondary cataract
04/19/1995CN1101722A Ophthalmic lens with anti-toxin agent
04/18/1995CA1335286C Labile ketone derivatives of 3-substituted-1-alkylamino 2-propanols and their use as .beta.-adrenergic blockers
04/13/1995WO1995009637A1 Highly sulfated maltooligosaccharides with heparin-like properties
04/13/1995CA2171465A1 Highly sulfated maltooligosaccharides with heparin-like properties
04/12/1995EP0647640A1 Process for the preparation of pilocarpine derivatives
04/12/1995EP0647627A1 1,2-Dihydro-2-oxo-3-methylsulfonylaminomethyl-pyridines as angiotensin II antagonists
04/12/1995CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity
04/11/1995US5405846 Mixture of 15-deoxyprostaglandin and adrenergic blocking agent
04/09/1995CA2133804A1 1,2-dihydro-2-oxo-3-methylsulfonylaminomethylpyridines
04/08/1995CA2133706A1 Process for the preparation of pilocarpine derivatives
04/06/1995WO1995009004A1 Compositions containing growth factors and antiplastic agents
04/06/1995WO1995009003A1 Compositions containing growth factors and antimetabolites
04/06/1995CA2149657A1 Compositions containing growth factors and antiplastic agents
04/06/1995CA2149528A1 Compositions containing growth factors and antimetabolites
04/05/1995EP0646112A1 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
04/05/1995CN1028105C Piperidine compound and their preparation
04/04/1995US5403951 Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anaesthesia of eyes, based thereon
04/04/1995US5403851 Substituted tryptamines, phenalkylamines and related compounds
04/04/1995US5403845 Muscarinic agonists
04/04/1995US5403598 Charging pressure reactor containing tear mixture with carbon dioxide and mixing to equilibrate and maintain bicarbonate
03/1995
03/30/1995WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995WO1995008535A1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents
03/30/1995CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/29/1995EP0645137A1 Use of quinones for the manufacture of a medicament for the treatment and prevention of a allergic rhinitis
03/29/1995EP0645056A1 Micromechanical thermoelectric sensor element.
03/29/1995EP0644765A1 Treatment of cellular hyperproliferation by inhibition of interleukin-1
03/29/1995CN1100721A Imidazopyridine
03/28/1995US5401851 Preparation of proline derivatives
03/28/1995US5401741 Cream with ofloxacin for inflammation of ears
03/28/1995US5401725 Treatment of tumors, rheumatoid arthritis and other diseases caused by vascular hyperplasia
03/27/1995EP0660836A4 Tricyclic derivatives of the thienodiazocine and thienothiadiazocine classes of compounds.
03/23/1995WO1995007985A1 Eotaxin: eosinophil chemotactic cytokine
03/23/1995WO1995007920A1 Nucleotide analogs
03/23/1995WO1995007919A1 Method for dosing therapeutic compounds
03/23/1995WO1995007898A1 Succinamic acid compound, process for producing the same, and use thereof
03/23/1995CA2171868A1 Method for dosing therapeutic compounds
03/23/1995CA2171756A1 Succinamic acid compound, production method thereof and use thereof
03/22/1995EP0644194A1 Pyridothiazineacetic acid compound, process for producing the same, and use thereof
03/22/1995EP0643709A1 4-(1-$i(H)-PYRROL-1-YL)IMIDAZOLES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY
03/22/1995EP0643581A1 Ocular androgen therapy in sjögren's syndrome
03/22/1995EP0643576A1 Alpha-2-adrenergic agonists for treating presbyopia
03/22/1995EP0471856B1 15-deoxyprostaglandin derivative
03/22/1995CA2132479A1 Pharmaceutical composition for treating or preventing allergic rhinitis
03/21/1995US5399714 One-pot reduction; acylation
03/21/1995US5399696 Excitatory amino acid receptor antagonists; nervous system disorders
03/21/1995US5399573 Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
03/21/1995CA2003198C Aqueous ophthalmic solutions and method for preserving same
03/16/1995WO1995007261A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
03/16/1995WO1995007103A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/16/1995WO1995007079A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
03/16/1995CA2170648A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
03/16/1995CA2170488A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
03/15/1995EP0642789A1 Remedy for glaucoma
03/15/1995EP0642504A1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
03/15/1995EP0642501A1 Novel pilocarpine derivatives and process for their preparation
03/15/1995EP0642351A1 New pharmaceutical uses of krill enzymes
03/15/1995EP0642332A1 Ophthalmic compositions containing a cyclosporin.
03/14/1995US5397797 Treatment of ocular hypertension with an ocular synergistic combination
03/09/1995WO1995006634A1 New 9-chloro-prostaglandin derivatives
03/09/1995CA2170613A1 New 9-chloro-prostaglandin derivatives
03/08/1995EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
03/08/1995EP0641329A1 Compounds having angiotensine ii antagonistic activity
03/08/1995EP0641203A1 Imidazolyl-alkenoic acids
03/02/1995WO1995005811A1 Method of inhibiting nitric oxide formation
03/02/1995WO1994025025A3 Systems for controlled release of pilocarpine
03/01/1995EP0640829A2 Scanning probe microscope
03/01/1995EP0640099A1 Peptides having tachykinin antagonist activity
03/01/1995EP0640084A1 6-AMINO SUBSTITUTED IMIDAZO 4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS
03/01/1995EP0640082A1 Heteroaromatic quinuclidinenes, their use and preparation
03/01/1995EP0639986A1 Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
03/01/1995EP0639980A1 Use of platelet derived growth factor in ophthalmic wound healing
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
02/1995
02/28/1995US5393788 Administering in the treatment of asthma or an allergic or inflammatory disease
02/28/1995US5392767 Atomizing a solution of furosemide
02/28/1995CA1334573C Aqueous antimicrobial ophthalmic solutions
02/23/1995WO1995005178A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
02/23/1995WO1995005176A1 Use of ergoline derivatives for the treatment of glaucoma
02/23/1995CA2169744A1 Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl sulfonamidomethyl and derivatives thereof as therapeutic agents
02/22/1995EP0639563A2 Use of cloprostenol, fluprostenol and their analogues for the manufacture of a medicament for the treatment of glaucoma and ocular hypertension
02/22/1995EP0639078A1 Method of treating eye disorders with silicone/fluorosilicone copolymer oil
02/22/1995EP0639073A1 Biologically active ureido derivatives useful as antimetastatic agents
02/22/1995EP0639070A1 Use of borate-polyol complexes in ophthalmic compositions
02/22/1995CN1099032A Derivative of benzoxazine, preparation and pharmaceutical application of same
02/21/1995US5391758 Heterocyclic amide derivatives
02/21/1995US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses
02/21/1995US5391559 Antiischemic agents; antihypoxic agents; antiedemic agents
02/16/1995WO1995004752A1 Therapeutic peptide derivatives
02/16/1995WO1995004532A1 Substituted 2-aminotetralins
02/15/1995CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors
02/14/1995US5389660 Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists
02/14/1995US5389659 C-linked pyrazole derivatives